This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

A proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs combined with metronomic temozolomide (CUSP9v3 treatment protocol) for recurrent glioblastoma

Provided treatments

  • Drug: Temozolomide
  • Drug: Aprepitant
  • Drug: Minocycline
  • Drug: Disulfiram
  • Drug: Celecoxib
  • Drug: Sertraline
  • Drug: Captopril
  • Drug: Itraconazole
  • Drug: Ritonavir
  • Drug: Auranofin
Tris trial is registered with FDA with number: NCT02770378. The sponsor of the trial is University of Ulm and it is looking for 10 volunteers for the current phase.
Official trial title:
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma